Perspective Therapeutics, Inc.

CATX
As of the close on Sep 25, 2026
Price
$2.52
Market cap
$288M
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Perspective Therapeutics, Inc. Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Perspective Therapeutics, Inc. — 10-K filed Mar 28, 2024

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Mar 4, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
Quantinno Capital Management LP 2026-03-31 65,494 Not shown SEC filing
Sterling Capital Management LLC 2026-03-31 2,072 Not shown SEC filing
VICTORY CAPITAL MANAGEMENT INC 2026-03-31 10,567 Not shown SEC filing
Spruce Street Capital LP 2026-03-31 2,627,107 Not shown SEC filing
CITADEL ADVISORS LLC 2026-03-31 3,566,504 Not shown SEC filing
FMR LLC 2026-03-31 313,658 Not shown SEC filing
Yu Fan 2026-03-31 1,055,409 Not shown SEC filing
Nicholson Wealth Management Group, LLC 2026-03-31 1,618,993 Not shown SEC filing
Dynamic Technology Lab Private Ltd 2026-03-31 14,056 Not shown SEC filing
SBI Securities Co., Ltd. 2026-03-31 1 Not shown SEC filing
MANUFACTURERS LIFE INSURANCE COMPANY, THE 2026-03-31 16,681 Not shown SEC filing
TD Waterhouse Canada Inc. 2026-03-31 200 Not shown SEC filing
DEUTSCHE BANK AG\ 2026-03-31 53,163 Not shown SEC filing
WINTON GROUP Ltd 2026-03-31 24,300 Not shown SEC filing
Police & Firemen's Retirement System of New Jersey 2026-03-31 20,787 Not shown SEC filing
Hills Bank & Trust Co 2026-03-31 872,200 Not shown SEC filing
Balyasny Asset Management L.P. 2026-03-31 2,994,460 Not shown SEC filing
ADAR1 Capital Management, LLC 2026-03-31 749,335 Not shown SEC filing
Koa Wealth Management, LLC 2026-03-31 25,975 Not shown SEC filing
AQR CAPITAL MANAGEMENT LLC 2026-03-31 26,716 Not shown SEC filing
  • Each value is checked against Perspective Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
  • Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.

120 filers have only one report here.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among Perspective Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

  • 2024-06-13 · Spoor Johan M.: Larger than 108 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2024-03-06 · Lantheus Holdings, Inc.: Larger than all 117 other insider purchases of Common Stock on file. SEC filing
  • 2024-01-24 · Puhlmann Markus: Larger than 115 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2023-12-19 · Puhlmann Markus: Larger than 116 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2023-12-18 · Hunt Jonathan Robert: Larger than 110 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2023-12-15 · Woods Lori A: Larger than 114 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2023-12-15 · Puhlmann Markus: Larger than 113 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2022-11-15 · Woods Lori A: Larger than 108 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2022-06-07 · Woods Lori A: Larger than 107 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2020-11-30 · Woods Lori A: Larger than 106 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2019-11-14 · Woods Lori A: Larger than 110 of the 117 other insider purchases of Common Stock on file. SEC filing
  • 2018-11-14 · Woods Lori A: Larger than 110 of the 117 other insider purchases of Common Stock on file. SEC filing

Independent insiders buying near the same time

Purchases & sales (open market or private)

SecurityCodePriceFiling
2025-11-13Hunt Jonathan Robert · Chief Accounting OfficerCommon StockP — Open market or private purchase+11,0002.03SEC filing
2025-11-12Williamson Robert F III · DirectorCommon StockP — Open market or private purchase+9,4982.10SEC filing
2025-03-31Williamson Robert F III · DirectorCommon StockP — Open market or private purchase+38,1452.14SEC filing
2025-03-31Woods Lori A · DirectorCommon StockP — Open market or private purchase+23,4752.13SEC filing
2025-03-28Williamson Robert F III · DirectorCommon StockP — Open market or private purchase+22,1922.27SEC filing
2025-03-28Spoor Johan M. · Chief Executive OfficerCommon StockP — Open market or private purchase+4,6502.21SEC filing
2025-03-28Spoor Johan M. · Chief Executive OfficerCommon StockP — Open market or private purchase+22,0262.24SEC filing
2025-03-28Graham Juan · Chief Financial OfficerCommon StockP — Open market or private purchase+33,3332.25SEC filing

Showing 8 of 10 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-03-02Martinez Maria E · DirectorStock option (right to buy)A — Grant, award, or other acquisition+50,000SEC filing
2026-03-02Puhlmann Markus · Chief Medical OfficerStock option (right to buy)A — Grant, award, or other acquisition+150,000SEC filing
2026-03-02Morich Frank · DirectorStock option (right to buy)A — Grant, award, or other acquisition+50,000SEC filing
2026-03-02Williamson Robert F III · DirectorStock option (right to buy)A — Grant, award, or other acquisition+50,000SEC filing
2026-03-02Hunt Jonathan Robert · Chief Accounting OfficerStock option (right to buy)A — Grant, award, or other acquisition+90,000SEC filing
2026-03-02HENSON HEIDI · DirectorStock option (right to buy)A — Grant, award, or other acquisition+50,000SEC filing
2026-03-02Spoor Johan M. · Chief Executive OfficerStock option (right to buy)A — Grant, award, or other acquisition+735,000SEC filing
2026-03-02Woods Lori A · DirectorStock option (right to buy)A — Grant, award, or other acquisition+50,000SEC filing

Showing 8 of 20 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.